| Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. | |
| | |
MedLine Citation:
|
PMID: 20959534 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. To date, the molecular mechanisms of DN remain largely unclear. The present study aimed to identify and characterize novel proteins involved in the development of DN by a proteomic approach. Proteomic analysis revealed that 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase 2 (HMGCS2), the key enzyme in ketogenesis, was increased fourfold in the kidneys of type 2 diabetic db/db mice. Consistently, the activity of HMGCS2 in kidneys and 24-h urinary excretion of the ketone body β-hydroxybutyrate (β-HB) were significantly increased in db/db mice. Immunohistochemistry, immunofluorescence, and real-time PCR studies further demonstrated that HMGCS2 was highly expressed in renal glomeruli of db/db mice, with weak expression in the kidneys of control mice. Because filtered ketone bodies are mainly reabsorbed in the proximal tubules, we used RPTC cells, a rat proximal tubule cell line, to examine the effect of the increased level of ketone bodies. Treating cultured RPTC cells with 1 mM β-HB significantly induced transforming growth factor-β1 expression, with a marked increase in collagen I expression. β-HB treatment also resulted in a marked increase in vimentin protein expression and a significant reduction in E-cadherin protein levels, suggesting an enhanced epithelial-to-mesenchymal transition in RPTCs. Collectively, these findings demonstrate that diabetic kidneys exhibit excess ketogenic activity resulting from increased HMGCS2 expression. Enhanced ketone body production in the diabetic kidney may represent a novel mechanism involved in the pathogenesis of DN. |
| | |
Authors:
|
Dongjuan Zhang; Hang Yang; Xiaomu Kong; Kang Wang; Xuan Mao; Xianzhong Yan; Yuan Wang; Siqi Liu; Xiaoyan Zhang; Jing Li; Lihong Chen; Jing Wu; Mingfen Wei; Jichun Yang; Youfei Guan |
Related Documents
:
|
16979414 - The messenger rna profiles in liver, hypothalamus, white adipose tissue, and skeletal m... 19966184 - Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db m... 15931394 - Role of leptin and melanocortin signaling in uremia-associated cachexia. 17568784 - Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating no... 2476984 - Identification of a type 1 insulin-like growth factor binding protein (igf bp) in serum... 4018454 - Inhibition of aortic histamine synthesis by alpha-hydrazinohistidine inhibits increased... |
Publication Detail:
|
Type: Journal Article Date: 2010-10-19 |
Journal Detail:
|
Title: American journal of physiology. Endocrinology and metabolism Volume: 300 ISSN: 1522-1555 ISO Abbreviation: Am. J. Physiol. Endocrinol. Metab. Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-01-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100901226 Medline TA: Am J Physiol Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: E287-95 Citation Subset: IM |
Affiliation:
|
Dept. of Physiology and Pathophysiology, Peking University Health Science Ctr., 38 Xueyuan Rd., Haidian District, Beijing, China 1000191. youfeiguan@bjmu.edu.cn. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed ...
Next Document: Multi-tissue, selective PPAR? modulation of insulin sensitivity and metabolic pathways in obese rats...